“showed a trend”

M-H patients showed a trend towards lower median overall survival in SqCC and ADC (75 vs 63 months p=0.21; 53 vs 50 months, p=0.14, Figure 3C,3D).

Arterioles in the skin also showed a trend towards differences in occlusion ratios, yet these results did not reach statistical significance ( p = 0.21 and 0.12) ( Fig 4 ).

Although not significant, the enhanced group showed a trend toward reduced need for additional sedation (3.1% vs 7.7%, P = 0.21), suggesting better overall tolerability of the enhanced preparation protocol (Table 7 ).

5, D and E ), the antiinflammatory cytokine IL-10 showed a trend toward increased level (PBS group, 10.88 ± 1.061 pg/mg of total protein; HJ6.3 group, 13.65 ± 1.855 pg/mg of total protein; P = 0.21).

In patients undergoing complex or noncomplex PCI, there was no significant difference between treatment groups, however, both subgroups showed a trend toward a reduction of major bleeding in the short‐term DAPT followed by ticagrelor monotherapy group (RR 0.62, 95% CI, 0.30–1.30, P = 0.21, I 2 = 72%; Figure 3d and RR 0.74, 95% CI, 0.48–1.14, P = 0.17, I 2 = 54%, respectively; Figure 3d ).

Conversely, MRG mutations showed a trend toward mutual exclusivity with recurrent alterations in CSF3R , JAK3 , ASXL2 ( p = 0.210, p = 0.350 and p = 0.587).

Blastocyst ET showed a trend toward a higher implantation and LB rates compared with day-3 ET cycles (implantation rate: 25.6% in single day-3 ET versus 40% single blastocyst ET, P = 0.2114; LBR: 18.6% single day-3 ET versus single blastocyst ET, P = 0.7165).

When comparing the HU FMT WT and HU FMT LIPUS groups, the protein expression levels of AKT and mTOR showed a trend towards upregulation in the HU FMT LIPUS group, albeit without reaching statistical significance (( p = 0.2123, p = 0.2065, respectively).

This pattern was significant in cl 2 (one-way repeated measures ANOVA, F (2,57) = 3.6125, p = 0.033), while cl 1 showed a trend (one-way repeated measures ANOVA, F (2,57) = 1.5916, p = 0.2125).

Although low socioeconomic status showed a trend towards lower risk, it was not statistically significant ( p = 0.213).

The data in the present study also showed a trend of higher percentage of patients with chronic obstructive pulmonary disease (P = 0.215), structural heart disease (P = 0.190), and coronary artery disease (P = 0.270) in the group with prolonged QTc although not reaching the level of statistical significance due to the small numbers.

5.9%; p=0.3827) and showed a trend towards higher mortality rates (6.6% vs. 3.9%; p=0.2159) compared to non-isolated matched controls (Table 3 (Tab. 3) ).

Furthermore, the level of pT181-tau showed a trend-level positive correlation ( Figure 2C , P = 0.218) with advanced age.

Although intrahepatic IL-17A data for patients with MASLD included in the gut mycobiome analysis were available for only a small subset of the cohort, the results showed a trend toward a positive correlation between gut mycobiome dysbiosis and increased hepatic IL-17A levels (Spearman correlation = 0.352, p = 0.218).

Increasing stem size showed a trend toward reduced risk (HR 0.88, 95% CI 0.72–1.08; p = 0.218), while glenosphere size had no apparent effect on implant survival (HR 1.05, 95% CI 0.91–1.21; p = 0.512).

Patients with myosteatosis in the PD‐1 inhibitor + CTLA‐4 inhibitor group had no difference in OS ( p = 0.723) from those without and showed a trend towards improved PFS ( p = 0.219).

The anti-inflammatory properties of asiatic acid were demonstrated through significant reductions in key pro-inflammatory cytokines, including tumor necrosis factor-α (32.036 versus 55.182 in controls, p = 0.026) and interleukin-1β (86.685 versus 123.02 in controls, p = 0.016), while interleukin-6 levels showed a trend toward reduction that did not reach statistical significance (155.0 versus 215.5, p = 0.219) [ 237 ].

In a sub-analysis of the 42 MACE events, female patients had a lower CCS (63.3 AU vs 265.2 AU, p < 0.05) and all-grade stenosis (40% vs 57.1%, p < 0.05); however, females showed a trend towards a relatively higher prevalence of non-calcified plaques (33.3% vs 14.3%, p = 0.22) and presence of any high-risk plaque feature (80% vs 71.4%, p = 0.35) (Fig. 4 ).

Although lysed samples in our preliminary analysis showed a trend to a lower cell count (mean count: 100.5 ± 26.4 cells vs. 159.0 ± 75.1 cells, p = 0.22) and lower RNA concentration (mean concentration: 75.5 ± 25.6 pg/μl vs. 91.5 ± 60.6 pg/μl, p = 0.65), no distinct effect of lysis on the RNA profile of hyalocytes could be inferred, as highlighted by the conducted principal component analysis (PCA, Additional File 2 A) and heatmap visualization (Additional File 2 B).

Elastography The Young’s modulus showed a trend to be higher in malignant thyroid nodules (median 27.6; 25th/75th percentile 17.3/63.4) than in benign nodules (median 19.5; 25th/75th percentile 11.7/32.3) ( p = 0.22).

This concordance suggested that patient-specific factors influence DWEK outcomes.[ 44 ] Two series[ 40 42 ] found that nonclearing patients had the highest preoperative pachymetry, but two larger series found no association between pachymetry and time to clearance.[ 32 44 ] Our study also showed a trend toward lower preoperative peripheral ECD with increased time to clearance that was not statistically significant ( P = 0.22).

Hospitalization rate (38.6% post-NPI vs 43.9% pre-NPI) and length of stay (median, 4 [IQR, 2–5] vs 4 [IQR, 3–6] days) were similar, while generalized linear models showed a trend toward fewer hospitalizations post-NPI (odds ratio [OR], 0.72 [95% CI, 0.42–1.23]; P = 0.22).

The OS rates were almost identical in both groups during the first 3 years and then showed a trend of improvement in the CCRT arm (68% versus 64% at 5 years and 61% versus 54% at 8 years (p=0.22).

Relative to water (placebo) control, 0.33 mg/kg pyrantel (labeled PYR in the figure) showed no significant impact on hookworm burdens (5% reduction, P = 0.87) whereas 1 mg/kg pyrantel showed a trend toward lower burdens that was not statistically significant (39% reduction, P = 0.22; Fig 5A ; S1 Table ).

Cytomegalovirus reactivation showed a trend towards higher frequency in patients with COVID-19 (21.9% vs. 11.3%, p = 0.22).